Meeting
2021 ASCO Annual Meeting
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts).
Authors
Carlo Resteghini
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Carlo Resteghini , Paolo Castelnuovo , Piero Nicolai , Ester Orlandi , Paolo Bossi , Barbara Vischioni , Alberto Schreiber , Nicola Alessandro Iacovelli , Paolo Battaglia , Davide Mattavelli , Nadia Facchinetti , Simone Gambazza , Giuseppina Calareso , Marco Ravanelli , Carla Facco , Tiziana Tartaro , Andrea Pietro Sponghini , Fabio Pagella , Luigi Mariani , Lisa F. Licitra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02099175
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6066)
DOI
10.1200/JCO.2021.39.15_suppl.6066
Abstract #
6066
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
A phase II trial evaluating efficacy of neo-/adjuvant EIA CTX, surgery, and radiation therapy in high-risk soft tissue sarcoma.
First Author: T. Schmitt
Poster
2023 ASCO Annual Meeting
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate as neoadjuvant therapy for osteosarcoma: A single-arm, exploratory phase II trial.
First Author: Qinglian Tang
Poster
2023 ASCO Annual Meeting
Updated safety and efficacy results of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC) from a phase II trial.
First Author: Dawei Chen
Poster
2022 ASCO Annual Meeting
Safety and efficacy of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): The results from a phase II single-arm trial.
First Author: Dawei Chen